Affiliation
Stem Cell and Leukaemia Proteomics Laboratory, Faculty of Medical and Human Sciences, University of Manchester, Christie Hospital, Kinnaird House, Kinnaird Road, Withington, Manchester, UK M20 4QL. runwin@manchester.ac.ukIssue Date
2007-11
Metadata
Show full item recordAbstract
Proteomics technologies are emerging as a useful tool in the identification of disease biomarkers, and in defining and characterising both normal physiological and disease processes. Many cellular changes in protein expression in response to an external stimulus or mutation can only be characterised at the proteome level. In these cases protein expression is often controlled by altered rates of translation and/or degradation, making proteomics an important tool in the analysis of biological systems. In the leukaemias, post-translational modification of proteins (e.g. phosphorylation, acetylation) plays a key role in the molecular pathology of the disease: such modifications can now be detected with novel proteomic methods. In a clinical setting, serum remains a relatively un-mined source of information for prognosis and response to therapy. This protein rich fluid represents an opportunity for proteomics research to benefit hematologists and others. In this review, we discuss the technologies available for the study of the proteome that offer realistic opportunities in haematology.Citation
How will haematologists use proteomics? 2007, 21 (6):315-26 Blood Rev.Journal
Blood ReviewsDOI
10.1016/j.blre.2007.07.002PubMed ID
17889973Type
ArticleLanguage
enISSN
0268-960Xae974a485f413a2113503eed53cd6c53
10.1016/j.blre.2007.07.002
Scopus Count
Collections
Related articles
- Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
- Authors: Apweiler R, Aslanidis C, Deufel T, Gerstner A, Hansen J, Hochstrasser D, Kellner R, Kubicek M, Lottspeich F, Maser E, Mewes HW, Meyer HE, Müllner S, Mutter W, Neumaier M, Nollau P, Nothwang HG, Ponten F, Radbruch A, Reinert K, Rothe G, Stockinger H, Tárnok A, Taussig MJ, Thiel A, Thiery J, Ueffing M, Valet G, Vandekerckhove J, Wagener C, Wagner O, Schmitz G
- Issue date: 2009 Oct
- Membrane proteomics for leukemia classification and drug target identification.
- Authors: Kohnke PL, Mulligan SP, Christopherson RI
- Issue date: 2009 Dec
- Recent advances in blood-related proteomics.
- Authors: Thadikkaran L, Siegenthaler MA, Crettaz D, Queloz PA, Schneider P, Tissot JD
- Issue date: 2005 Aug
- Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
- Authors: Sinchaikul S, Hongsachart P, Sriyam S, Tantipaiboonwong P, Phutrakul S, Chen ST
- Issue date: 2008 Sep-Oct
- Clinical applications of molecular haematology: flow cytometry in leukaemias and myelodysplastic syndromes.
- Authors: Dalal BI
- Issue date: 2007 Aug